- Home
- PRVA vs AMRX Comparison
PRVA vs AMRX Comparison
Compare PRVA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- AMRX
- Stock Information
- Founded
- PRVA 2007
- AMRX 2002
- Country
- PRVA United States
- AMRX United States
- Employees
- PRVA N/A
- AMRX N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PRVA Technology
- AMRX Health Care
- Exchange
- PRVA Nasdaq
- AMRX Nasdaq
- Market Cap
- PRVA 2.8B
- AMRX 2.3B
- IPO Year
- PRVA 2021
- AMRX N/A
- Fundamental
- Price
- PRVA $22.76
- AMRX $7.32
- Analyst Decision
- PRVA Strong Buy
- AMRX Strong Buy
- Analyst Count
- PRVA 14
- AMRX 4
- Target Price
- PRVA $27.93
- AMRX $11.50
- AVG Volume (30 Days)
- PRVA 770.2K
- AMRX 1.9M
- Earning Date
- PRVA 05-08-2025
- AMRX 05-02-2025
- Dividend Yield
- PRVA N/A
- AMRX N/A
- EPS Growth
- PRVA N/A
- AMRX N/A
- EPS
- PRVA 0.12
- AMRX N/A
- Revenue
- PRVA $1,801,244,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- PRVA $90.57
- AMRX $10.20
- Revenue Next Year
- PRVA $10.43
- AMRX $7.15
- P/E Ratio
- PRVA $189.74
- AMRX N/A
- Revenue Growth
- PRVA 6.79
- AMRX 13.42
- 52 Week Low
- PRVA $16.37
- AMRX $6.29
- 52 Week High
- PRVA $26.09
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- PRVA 41.82
- AMRX 46.61
- Support Level
- PRVA $22.72
- AMRX $7.02
- Resistance Level
- PRVA $23.73
- AMRX $7.39
- Average True Range (ATR)
- PRVA 0.75
- AMRX 0.18
- MACD
- PRVA -0.22
- AMRX -0.00
- Stochastic Oscillator
- PRVA 16.20
- AMRX 45.80
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.